These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3524172)
1. Hemodynamic effects of moricizine at rest and during supine bicycle exercise: results in patients with ventricular tachycardia and left ventricular dysfunction. Seals AA; English L; Leon CA; Wierman AM; Young JB; Zoghbi W; Quinones MA; Mahler SA; Roberts R; Pratt CM Am Heart J; 1986 Jul; 112(1):36-43. PubMed ID: 3524172 [TBL] [Abstract][Full Text] [Related]
2. Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments. Pratt CM; Podrid PJ; Seals AA; Young JB; Hession M; Lampert S; QuiƱones M; Lown B Am J Cardiol; 1987 Oct; 60(11):73F-78F. PubMed ID: 3310589 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial. Pratt CM; Wierman A; Seals AA; English L; Leon C; Young JB; Quinones MA; Roberts R Circulation; 1986 Apr; 73(4):718-26. PubMed ID: 3512124 [TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction. Seals AA; Haider R; Leon C; Francis M; Young JB; Roberts R; Pratt CM Circulation; 1987 Apr; 75(4):800-8. PubMed ID: 3549044 [TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, hemodynamic effects, and pharmacokinetics of high-dose moricizine during short- and long-term therapy. Salerno DM; Sharkey PJ; Granrud GA; Asinger RW; Hodges M Clin Pharmacol Ther; 1987 Aug; 42(2):201-9. PubMed ID: 3301153 [TBL] [Abstract][Full Text] [Related]
6. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias. Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852 [TBL] [Abstract][Full Text] [Related]
7. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Thadani U; West RO; Mathew TM; Parker JO Am J Cardiol; 1977 May; 39(6):776-83. PubMed ID: 871106 [TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine. Podrid PJ; Beau SL Am J Cardiol; 1990 Feb; 65(8):56D-64D; discussion 68D-71D. PubMed ID: 2407092 [TBL] [Abstract][Full Text] [Related]
11. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias. Fitton A; Buckley MT Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581 [TBL] [Abstract][Full Text] [Related]
12. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias. Hession MJ; Lampert S; Podrid PJ; Lown B Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of moricizine in malignant ventricular arrhythmias. Horowitz LN Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535 [TBL] [Abstract][Full Text] [Related]
14. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia. Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950 [TBL] [Abstract][Full Text] [Related]
15. Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial. Singh SN; DiBianco R; Gottdiener JS; Ginsberg R; Fletcher RD Am J Cardiol; 1984 Mar; 53(6):745-50. PubMed ID: 6367416 [TBL] [Abstract][Full Text] [Related]
16. Prediction of left ventricular function during supine bicycle ergometer exercise in angina-free patients with old myocardial infarction. Kamihara S; Yokota M; Inagaki H; Iwase M; Matsunami T; Yoshida J; Miyahara T; Koide M; Hayashi H Clin Cardiol; 1990 Jul; 13(7):480-4. PubMed ID: 2364582 [TBL] [Abstract][Full Text] [Related]
17. Cardiac performance at rest and during exercise in normal subjects. Parker JO; Thadani U Bull Eur Physiopathol Respir; 1979; 15(5):935-49. PubMed ID: 508986 [TBL] [Abstract][Full Text] [Related]
19. The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography. Mahmarian JJ; Verani MS; Hohmann T; Hill R; Thornton BC; Bolli R; Young JB; Roberts R; Pratt CM Circulation; 1987 Aug; 76(2):324-31. PubMed ID: 3301053 [TBL] [Abstract][Full Text] [Related]
20. Left and right ventricular function at rest and during bicycle exercise in the supine and sitting positions in normal subjects and patients with coronary artery disease. Assessment by radionuclide ventriculography. Manyari DE; Kostuk WJ Am J Cardiol; 1983 Jan; 51(1):36-42. PubMed ID: 6849265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]